Albright Daniel MD is categorized under Orthopedic Doctors and Physicians in Cary, NC .
Albright Daniel MD was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Daniel Albright at the company’s single location by writing to 222 Ashville Avenue # 20, Cary, North Carolina NC 27518 or by phoning (919) 781-5600. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Albright Daniel MD |
| Contact Person: | Daniel Albright |
| Address: | 222 Ashville Avenue # 20, Cary, North Carolina 27518 |
| Phone Number: | (919) 781-5600 |
| Website Address: | raleighortho.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Orthopedic Doctors and Physicians |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Albright Daniel MD was started in 0 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Daniel Albright for inquiries that concern Albright Daniel MD by calling the company number (919) 781-5600, as your correspondence is most welcome. Additionally, the physical location of the single location of Albright Daniel MD can be found at the coordinates 35.73971,-78.78474 as well as the street address 222 Ashville Avenue # 20 in Cary, North Carolina 27518.
For its online presence, you may visit Albright Daniel MD’s website at raleighortho.com and engage with its social media outlets through on Twitter and on Facebook.